Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of ...

Researchers from the Karolinska Institutet in Sweden have found a potential new treatment for non-alcoholic fatty liver ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial ...

Liver disease encompasses a range of conditions that affect the liver, an essential organ involved in digestion, metabolism, and ridding the body of toxins. Common symptoms of liver disease ...